PDE10A anticorps (AA 300-350)
Aperçu rapide pour PDE10A anticorps (AA 300-350) (ABIN2747045)
Antigène
Voir toutes PDE10A AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 300-350
-
Purification
- Affinity Purified
-
Immunogène
- Synthetic peptide taken within amino acid region 300-350 on human PDE10A2 protein common to all PDE10A variants.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.7 μg/μL
-
-
-
: "Characterization of the binding properties of T-773 as a PET radioligand for phosphodiesterase 10A." dans: Nuclear medicine and biology, Vol. 42, Issue 2, pp. 146-54, (2015) (PubMed).
: "Levodopa-induced dyskinesias are associated with transient down-regulation of cAMP and cGMP in the caudate-putamen of hemiparkinsonian rats: reduced synthesis or increased catabolism?" dans: Neurochemistry international, Vol. 79, pp. 44-56, (2015) (PubMed).
: "Phosphodiesterase 10A controls D1-mediated facilitation of GABA release from striato-nigral projections under normal and dopamine-depleted conditions." dans: Neuropharmacology, Vol. 76 Pt A, pp. 127-36, (2014) (PubMed).
: "Phosphodiesterase 2 inhibitors promote axonal outgrowth in organotypic slice co-cultures." dans: Neuro-Signals, Vol. 21, Issue 3-4, pp. 197-212, (2013) (PubMed).
: "PDE10A and PDE10A-dependent cAMP catabolism are dysregulated oppositely in striatum and nucleus accumbens after lesion of midbrain dopamine neurons in rat: a key step in parkinsonism physiopathology." dans: Neurobiology of disease, Vol. 43, Issue 1, pp. 293-303, (2011) (PubMed).
: "The role of the PDE4D cAMP phosphodiesterase in the regulation of glucagon-like peptide-1 release." dans: British journal of pharmacology, Vol. 157, Issue 4, pp. 633-44, (2009) (PubMed).
: "PDE9A, PDE10A, and PDE11A expression in rat trigeminovascular pain signalling system." dans: Brain research, Vol. 1281, pp. 25-34, (2009) (PubMed).
: "Development of a cell-based assay for screening of phosphodiesterase 10A (PDE10A) inhibitors using a stable recombinant HEK-293 cell line expressing high levels of PDE10A." dans: Biotechnology and applied biochemistry, Vol. 49, Issue Pt 2, pp. 129-34, (2008) (PubMed).
: "Chronic haloperidol and clozapine produce different patterns of effects on phosphodiesterase-1B, -4B, and -10A expression in rat striatum." dans: Neuropharmacology, Vol. 54, Issue 4, pp. 745-54, (2008) (PubMed).
: "Immunohistochemical distribution of cyclic nucleotide phosphodiesterase (PDE) isoenzymes in the human vagina: a potential forensic value?" dans: Journal of forensic and legal medicine, Vol. 14, Issue 5, pp. 270-4, (2007) (PubMed).
: "Immunohistochemical description of cyclic nucleotide phosphodiesterase (PDE) isoenzymes in the human labia minora." dans: The journal of sexual medicine, Vol. 4, Issue 3, pp. 602-608, (2007) (PubMed).
: "Cyclic adenosine monophosphate and cyclic guanosine monophosphate-phosphodiesterase isoenzymes in human vagina: relation to nitric oxide synthase isoforms and vasoactive intestinal polypeptide-containing nerves." dans: Urology, Vol. 65, Issue 3, pp. 604-10, (2005) (PubMed).
-
-
- PDE10A (phosphodiesterase 10A (PDE10A))
-
Autre désignation
- PDE10A
-
UniProt
- Q9Y233
-
Pathways
- cAMP Metabolic Process
Antigène
-